Our study showed that Th1-type (IFN-γ) and Th2-type (IL-4) cytokine responses specific to HA1 were significantly induced, which may have contributed to broadening the protection efficiency of our vaccine candidate pSIP401-HA1-ZN-3 against divergent influenza subtypes. The gene discussed is IFNG; the disease is influenza.